Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

BioNTech, Germany and Singapore

Digest more
Top News
Overview
 · 1d · on MSN
BioNTech to shed jobs, plants as Covid vaccine sales dwindle
The company said it would exit operations at some manufacturing plants in Germany and Singapore, and that as many as 1,860 roles will be affected.

Continue reading

 · 1d · on MSN
BioNTech to close sites in Germany, Singapore affecting 1,860 staff
Fierce Pharma · 1d
BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
 · 1d
Germany: BioNTech shutting down COVID vaccine production entirely, 1,860 jobs at risk
The Mainz-based company BioNTech that shot to global notoriety amid the COVID-19 pandemic for its work on one of the first mRNA coronavirus vaccines has announced drastic restructuring plans.

Continue reading

 · 15h
BioNTech to Shed Jobs, Plants as Covid Vaccine Sales Dwindle
Pharm Exec · 1d
BioNTech Releases First Quarter Results for 2026
8h

BioNTech Expands Oncology Trials And Reshapes Manufacturing As Investors Weigh Upside

BioNTech (NasdaqGS:BNTX) has started five additional pivotal oncology trials in collaboration with Bristol Myers Squibb. The company has expanded its oncology pipeline with new candidates entering later stage development.
Devdiscourse
1d

BioNTech Announces Major Site Closures Amid Executive Departures

BioNTech is planning site closures affecting up to 1,860 jobs and will buy back $1 billion in shares after announcing the departure of its co-founders. Production of its COVID-19 vaccine will be transferred to Pfizer,
1d

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and
4hon MSN

BioNTech faces its biggest post pandemic crisis

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?
9h

Germany says vaccine supply secure despite BioNTech production loss

A German government ​spokesperson said on ‌Wednesday that the loss of ​BioNTech vaccine ​production in the country ⁠can be ​offset by other ​companies.
The Peninsula Qatar
1d

BioNTech to cut up to 1,860 jobs as Covid jab sales drop

Germany s BioNTech said Tuesday it will halt operations at several sites, in a move affecting up to 1,860 jobs, as sales of its
BioSpace
1d

BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs

The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.
1d

Germany: BioNTech shutting down COVID vaccine production

The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to partner Pfizer. BioNTech is restructuring to focus on research and illnesses like cancer.
1don MSN

BioNTech to slash 25% of workforce as losses widen. The stock falls.

The German biotech is struggling to redefine itself post-Covid, and an oncology push is part of the solution.
  • Privacy
  • Terms